StockTipsArenaBeta

BUY Dr. Lal Path Labs Ltd. — Sandip Sabharwal

BUYDr. Lal Path Labs Ltd.
Dr. Lal Path Labs share price target & all analyst calls

bySandip SabharwalHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via NDTV Profit (Live)

Entry₹1,954.2Inferred
Target₹2,090
Total upside +6.95% (call closed)
Stop lossNot given
At expiry₹1,890.924 Aug 2026, 3:30 pm
Expired-3.24%
Follow Sandip Sabharwal for new callsGet alertsWatch LALPATHLAB for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Aug 2026
4 supporting0 opposing
Supports the BUY call (4)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·19 Aug · 5d ago

Shri Bajrang Alliance Annual Report: Profit Up, Capacity Expansion Approved

NewsGoogle News·17 Aug · 1w ago

(opens in new tab)

Metropolis Healthcare: చిన్న పట్టణాల్లో దూసుకుపోతోంది.. లాభాల్లో **26%** వృద్ధి!

NewsGoogle News·6 Aug · 2w ago

(opens in new tab)

Metropolis Healthcare शेअरमध्ये तेजी! टियर-II/III शहरांमधील विस्ताराने नफा **26%** ने वाढला

NewsGoogle News·6 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Lal Path Labs

All analyst calls on Dr. Lal Path Labs

More from Sandip Sabharwal

Every call and its outcome